In cultured LLC cells and MMTV-PyMT tumour cells, AKTi addition led to a reduction of cell viability by 37% and 35%, respectively, regardless of the inclusion of TNFα and/or IFNγ (Fig. 9f, g). The gene discussed is TNF; the disease is neoplasm.